Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice
Authors
Keywords
Everolimus, Sorafenib, Xenografts, Non-competitive interaction model, PBPK-PD, Pancreatic cancer
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 5, Pages 1231-1240
Publisher
Springer Nature
Online
2013-03-02
DOI
10.1007/s00280-013-2117-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
- (2013) Dipti K. Pawaskar et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interactions of Everolimus and Sorafenib in Pancreatic Cancer Cells
- (2012) Dipti K. Pawaskar et al. AAPS Journal
- Sorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
- (2011) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
- (2011) A.-C. Piguet et al. MOLECULAR CANCER THERAPEUTICS
- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
- (2011) V. S. Rodrik-Outmezguine et al. Cancer Discovery
- Novel Agents on the Horizon for Cancer Therapy
- (2009) W. W. Ma et al. CA-A CANCER JOURNAL FOR CLINICIANS
- mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
- (2009) H. A. Lane et al. CLINICAL CANCER RESEARCH
- The Applicability of mTOR Inhibition in Solid Tumors
- (2009) I.R. Konings et al. CURRENT CANCER DRUG TARGETS
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma
- (2009) Yunsheng Hsieh et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Pancreatic Cancer
- (2008) Anirban Maitra et al. Annual Review of Pathology-Mechanisms of Disease
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
- (2008) J LOPICCOLO et al. DRUG RESISTANCE UPDATES
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors
- (2008) Anne O'Donnell et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Inhibition of MAPK and mTOR Signaling Inhibits Growth, Induces Cell Death, and Abrogates Invasive Growth of Melanoma Cells
- (2008) Konstantinos G. Lasithiotakis et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Development of a rapid and sensitive LC–MS/MS assay for the determination of sorafenib in human plasma
- (2007) Lokesh Jain et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now